SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001104659-23-116366
Filing Date
2023-11-09
Accepted
2023-11-09 17:07:46
Documents
2
Group Members
ASTRAZENECA HOLDINGS B.V.

Document Format Files

Seq Description Document Type Size
1 SC 13D tm2330279d1_sc13d.htm SC 13D 88782
2 EXHIBIT 1 tm2330279d1_ex1.htm EX-1 6390
  Complete submission text file 0001104659-23-116366.txt   96935
Mailing Address 1 FRANCIS CRICK AVENUE CAMBRIDGE BIOMEDICAL CAMPUS CAMBRIDGE X0 CB2 0AA
Business Address 1 FRANCIS CRICK AVENUE CAMBRIDGE BIOMEDICAL CAMPUS CAMBRIDGE X0 CB2 0AA 011 44 20 7304 5000
ASTRAZENECA PLC (Filed by) CIK: 0000901832 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: SC 13D
SIC: 2834 Pharmaceutical Preparations

Mailing Address 8 RUE DE LA CROIX JARRY PARIS, LLE-DE-FRANCE I0 75013
Business Address 8 RUE DE LA CROIX JARRY PARIS, LLE-DE-FRANCE I0 75013 33181691600
Cellectis S.A. (Subject) CIK: 0001627281 (see all company filings)

IRS No.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-89356 | Film No.: 231393668
SIC: 2836 Biological Products, (No Diagnostic Substances)